Title: Strategies for Overcoming Multidrug Resistance in Cancer

Time: May 23, 2025 (Friday) 15:00-16:00

Venue: Multi-Function Hall, 2nd Floor, Wang Changlai Building, Ningbo University Health Science Center

Speaker Profile: Zhe-Sheng Chen

Prof. Zhe-Sheng Chen is a Tenured Professor and Doctoral Supervisor at St. John's University, USA, serving as the Director of the Institute of Biotechnology and the Director of the Cancer Pharmacology Division, Department of Pharmacy. A renowned scholar in the field of cancer pharmacology, his research focuses on mechanisms of tumor drug resistance and the development of resistance-reversing agents.

Prof. Chen has published over 550 high-impact papers in leading international journals such as Chemical Society Review, Cell Research, Advanced Materials, Nature Communications, Advanced Science, Molecular Cancer, Signal Transduction and Targeted Therapy, Drug Resistance Updates, Cancer Research, Clinical Cancer Research, and Journal of Biological Chemistry. His work has been cited more than 40,000 times, with an H-index of 98. He has received prestigious awards including the AACR Young Scientist Award and the Young Investigator Award at International Cancer Conferences. He is listed in the "Career Scientific Impact Ranking" and the "2023 Annual Scientific Impact Ranking."

Currently, Prof. Chen serves as the Editor-in-Chief of Drug Resistance Updates and Recent Patents on Anticancer Drug Discovery, and as an editorial board member for 27 journals including Cancer Letters, Chinese Medicine, and MedComm. He is also a reviewer for over 200 journals such as Science, Nature Communications, and Nature Reviews Cancer. Additionally, he evaluates grants for the National Natural Science Foundation of China (NSFC), NIH (USA), and other funding agencies worldwide.